Holen Sie sich die Stockscreener-App
37.86
2.55%
-0.99
Handel nachbörslich:
37.65
-0.21
-0.55%
Finanzdaten der Verona Pharma Plc Adr-Aktie (VRNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
42.44%
27.20
|
19.09 | 16.31 | 9.965 | 22.20 |
| Interest Income/Expense |
154.57%
1.586
|
0.623 | 0.401 | 0.74 | 0.293 |
| Operating Income/Loss |
42.44%
-27.20
|
-19.09 | -16.31 | -9.965 | -22.20 |
| Nonoperating Income/Loss |
56.04%
2.158
|
4.909 | 1.668 | 1.468 | 5.629 |
| Income/Loss From Continuing Operations Before Tax |
76.52%
-25.04
|
-14.19 | -14.64 | -8.497 | -16.57 |
| Income Tax Expense/Benefit |
1,523%
0.754
|
-0.053 | 0.044 | 0.31 | 0.173 |
| Income/Loss From Continuing Operations After Tax |
82.52%
-25.79
|
-14.13 | -14.69 | -8.807 | -16.74 |
Net Income/Loss
|
82.52%
-25.79
|
-14.13 | -14.69 | -8.807 | -16.74 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
23,861%
645.70
|
2.6948 | 638.24 | 634.47 | 621.45 |
| Diluted Average Shares |
23,861%
645.70
|
2.6948 | 638.24 | 634.47 | 621.45 |
| Basic Earnings Per Share |
33.33%
-0.04
|
-0.03 | -0.02 | -0.01 | -0.03 |
| Diluted Earnings Per Share |
33.33%
-0.04
|
-0.03 | -0.02 | -0.01 | -0.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):